SynthesisFrontiers in oncology2021

Efficacy and Safety of Thalidomide As a Pre-Medication of Chemotherapy-Induced Nausea and Vomiting (CINV) Following Highly Emetogenic Chemotherapy (HEC): A Systematic Review and Meta-Analysis.

Jiyi Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.